HE WEI-WU purchased 10.2% of their position (480K shares) of CASI PHARMACEUTICALS, INC (DE) on the open market
Open‑market purchase worth $613.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/20/2021ACC: 0001104659-21-108182
Director10% Owner
Since Dec 2018
+480K
Net shares
Net buyer
$613.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
480K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+300K
Price / share
$1.29
Trade value
$387K
% of position
6.4%
8/18/2021
4.68M→4.98M
Common Stock
Direct
Shares
+180K
Price / share
$1.26
Trade value
$226.80K
% of position
3.6%
8/19/2021
4.98M→5.16M
Total
Net shares
+480K
Net value
$613.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2021 | P · Purchase | +300K | $1.29 | $387K | 6.4% | 4.68M | 4.98M |
| Common Stock Direct | 8/19/2021 | P · Purchase | +180K | $1.26 | $226.80K | 3.6% | 4.98M | 5.16M |
| Total | +480K | $613.80K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned3M
Common Stock
IndirectShares owned7.53M
Common Stock
IndirectShares owned441.07K
Total
10.97M indirect10.97M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3M | Indirect |
| Common Stock | 7.53M | Indirect |
| Common Stock | 441.07K | Indirect |
| Total | 10.97M | 10.97M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported